Washington D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934
For period ending 22 November 2018
GlaxoSmithKline plc
(Name of registrant)

980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)

Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F

Form 20-F x     Form 40-F


Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.

Yes      No x
 GlaxoSmithKline plc
GSK publishes provisional dividend dates
GSK announces the following dividend dates for 2019.
Results announcement date
Ex-dividend date
Record date
Last date for DRIP elections
Payment date
Q1 2019
Wednesday 1 May
Thursday 16 May
Friday 17 May
Thursday 20 June
Thursday 11 July
Q2 2019
Wednesday 24 July
Thursday 8 August
Friday 9 August
Thursday 19 September
Thursday 10 October
Q3 2019
Wednesday 30 October
Thursday 14 November
Friday 15 November
Monday 16 December
Thursday 9 January 2020
Q4 2019
Wednesday 5 February 2020
Thursday 20 February 2020
Friday 21 February 2020
Tuesday 19 March 2020
Thursday 9 April 2020
These dates are indicative and may be subject to change.  
V A Whyte
Company Secretary
22 November 2018
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GlaxoSmithKline plc
Date: November 22, 2018 
Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc